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ABSTRACT  
Background: Thrombocytopenia is a common finding in pregnancy, occurring in 
approximately 10 – 16 % of women. the normal range of platelet counts decreases, and it is 
not uncommon for the platelet counts to decrease as pregnancy progresses. Lower platelet 
count observed in the pregnant are due to normal physiologic changes, and has many 
common causes including gestational thrombocytopenia, viral and bacterial infection and 
preeclampsia complicated by hemolysis. Objective: the objective was to investigate 
thrombocytopenia during different stages of pregnancy. Materials and methods: Sixty three 
pregnant women were included in this study from different clinic in Derna city. Mean age (28 
± 1.4) year with a range (20 – 1.4) year. At the same time a group of Sixty three healthy non 
pregnant women mean age (29 ± 2.2) with a range (23 – 45) year to compare platelets count 
between them. By automated cell counter platelets from all pregnant and non pregnant were 
estimated. Results:  Pregnant women had lower platelets count (mean 193× 109/l) as 
compared to healthy non pregnant women (mean 250 × 109/l). there was significant decrease 
in platelet count in pregnant as compare with non pregnant P ≤ 0.001. Conclusion: Platelet 
counts were performed on sixty three normal patients at different stages of pregnancy. 
Patients with complications of pregnancy known to influence the platelet count were excluded 
from the study. There was significant decrease in platelet count during pregnancy.  




Thrombocytopenia is defined as a platelet count of less than 
150×109/l. Normal pregnancy is generally thought not to affect 
the platelet count[1] but it has been suggested that the normal 
range is lower in pregnancy, and that the count falls in the 
third trimester. [2-4]  
Detection of thrombocytopenia in pregnant requires 
consideration. the condition associated with pregnancy which 
cause thrombocytopenia. an additional important 
consideration is the possible effect on the fetus and its 
delivery. 
 Thrombocytopenia occurs in approximately 10- 16 % of 
pregnant women[3].    Thrombocytopenia in pregnancy has 
many common causes, including gestational 
thrombocytopenia, viral and bacterial infection and 
preeclampsia complicated by hemolysis, acute fatty liver, 
disseminated intravascular coagulation, thrombotic 
 Gestational thrombocytopenia is considered the most 
prevalent cause of thrombocytopenia in pregnancy and 
accounts for 65% - 80% of cases of thrombocytopenia during 
pregnancy[1,4]. It is defined by a platelet count of no less than 
70 x 109, especially during the third trimester. Increased blood 
volume, an increase in platelet activation, and increased 
The history and physical examination are important in 
providing clues to the diagnosis of thrombocytopenia in 
pregnancy, either by disclosure of preexisting 
thrombocytopenia or bleeding symptoms or by clinical 
findings of hypertension, edema, neurologic abnormalities, or 
signs of autoimmune disease such as idopathic 
thrombocytopenia purpura (ITP).  
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thrombocytopenic purpura and hemolytic uremic syndrome.[2] 
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platelet clearance contribute to a physiologic decrease in the 
platelet count[3].  
ITP occurs in approximately 2 of 1000 pregnant women[4]. ITP
 may develop at any time during pregnancy, but is often initially
 recognized in the first trimester and is the most common
 cause   of   isolated    thrombocytopenia in  this time. It
thrombocytopenia in pregnancy.[3,5] 
Naturally, ITP can present for the first time during a 
pregnancy.  Unless platelet counts are markedly decreased, 
or another cause of thrombocytopenia is obvious, the 
differential diagnosis between ITP and gestational 
thrombocytopenia might be difficult in view of recent data.  
In ITP autoimmune IgG cross the placental barrier and bind to 
relevant epitopes of fetal platelets, which are then cleared by 
the fetal reticuloendothelial system. Although neonatal 
thrombocytopenia was found to be more common in infants 
of mothers with ITP, no correlation was found between 
neonatal platelet counts and maternal platelet counts, or 
platelet-associated immunoglobulin's in maternal or cord 
blood.[6] 
Elevated liver enzymes and low platelet count (HELLP) and 
preeclampsia syndrome are considered to be the cause of 
thrombocytopenia in pregnancy in about 21% of cases.[7,8] 
Platelets count return to normal within 3-5 days of 
deleveliry.[3] The HELLP syndrome is associated with serious 
clinical problems, both in mothers and in their babies. These 
problems include disseminated intravascular coagulation 
(DIC), placental abruption, acute renal failure, and adult 
respiratory distress syndrome (ARDS). 
The maternal mortality is reported to be around 3.3%, while 
the prenatal mortality of babies is reported to be around 
22%. 
There are additional, rarer causes of thrombocytopenia 
during pregnancy, including thrombotic thrombocytopenic 
purpura (TTP), hemolytic uremic syndrome (HUS), 
disseminated intravascular coagulation (DIC), systemic lupus 
erythematosus (SLE), anti-phospholipid antibodies syndrome 
(APLA), or it may be induced by drugs (such heparin). 
The evaluation of the pregnant patient with 
thrombocytopenia need the history and physical examination 
which is important in providing clues to the diagnosis of 
thrombocytopenia in pregnancy, either by disclosure of 
preexisting thrombocytopenia or bleeding symptoms or by 
clinical findings of hypertension, abnormalities or signs of 
autoimmune disease.    
The aim of this study was to investigate prevalence 
thrombocytopenia at different stages of pregnancy in Derna 
city. 
MATERIAL AND METHODOLOGY 
Study design: A case control study was designed evaluate 
platelets count in pregnant women who never suffering any 
disease and compare their finding platelets count with 
healthy non pregnant women. 
Ethical approval: Approval was granted from the Research 
and Ethics Committee of the faculty. Consent was gotten 
from all participated patients. 
Sample size and sampling method: 
A sample of 126 women, 63 were pregnant women and 63 
were healthy non pregnant women were included in the 
study and measure platelets count by automated cell counter 
for all. 
Inclusion criteria: Pregnant women aged 20 year and more 
were selected at different stage of pregnancy, most of them 
were multiple pregnant, control (non pregnant) aged 29 and 
more were selected randomly.   
Exclusion criteria: the study include healthy pregnant women 
who did not use any drugs affect platelets count and did not 
have any previous disease affect platelet 
Methodology: By Automated cell counter platelets ((sysmex 
X 21) from all pregnant and controlled were estimated. 
Five ml of blood samples from pregnant and controlled were 
collected by vein puncture in EDTA container. A whole blood 
specimen containing formed cellular elements, 20 µl of blood 
is diluted with a premeasured 1.9 ml volume of ammonium 
oxalate, sorensens phosphoate buffer, thimerosal, and 
purified water. Fresh capillary or anticoagulant whole blood 
is added to the diluents, which lyses erythrocytes but 
preserves platelets for 1:10 dilution of the blood.[9] The 
diluted specimen is added to a hemocytometer for manual 
enumeration of platelets in special circumstances.  
Statistical analysis: Result are expressed as mean values ± 
SD. Data were analyzed by t test using. Significant difference 
was considered to exist at P value less than 0.05. 
RESULT  
A total of 126 women, 63 pregnant women mean age (28.6 ± 
1.4) year with a range  
(20-41) year, and 63 non pregnant women as healthy control 
mean age (29.4±2.2) with a range (23-45) year. Forty three of 
the pregnant age of gestation was ≥ 30 weeks and Twenty 
age of gestation between 15-10 weeks.  
In this study we compare platelets count in pregnant with 
platelets count in non pregnant, without comparing age of 
gestation. Platelets count in pregnant were (193 ± 51.69 × 
109/ l) whereas platelets count in non pregnant were (250± 
59.96 × 109 / l). 
There was significant decrease in platelet count in pregnant 
as compare with non pregnant P ≤ 0,001 (Table 1). 
Table 1. Platelet in pregnant, non pregnant 
Pregnant Control Parameters 
33 33 Number of cases 
121  - 342 164  - 401 Observed range 
193.6±51.92 250±59.6 M ± SD 
in pregnant vs non pregnant :  platelets   t = 5.64         df = 124     
P ≤ 0.001, P ≥ 0.05 not significant ; P ≤ o.o5  significant. 
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is characterized by a moderate to severe decrease in the
platelet count, and constitutes approximately 5% of cases of 
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DISCUSSION  
Low platelets during pregnancy are a common finding during 
pregnancy. The standard platelet count is between 150 to 
400 million per milliliter of blood. However, this count may 
vary from person to person. You are said to have a low 
platelet count during pregnancy when the count goes below 
the prescribed standard.  
Blood platelets in pregnancy are normal most often but drop 
slightly in just about 8% of women. Low blood platelets in 
pregnancy are termed as a condition called gestational 
thrombocytopenia. This usually happens during 
the pregnancy third trimester but has no untoward reaction 
on the fetus and returns to normal once the child is born. 
The present study was aimed at investigating 
thrombocytopenia during pregnancy. In this study 63 
pregnant women were included, platelet count measured in 
all blood samples as a part of complete blood count , at the 
same time we measured randomly in others 63 healthy 
females (non pregnant) as a control subject, data statistically 
was revealed that pregnant woman had significantly 
decrease  platelet counts  as compared to non pregnant 
(control subjects).  
Thrombocytopenia is the second most common hematologic 
abnormality during pregnancy and is usually a benign 
condition.  
Parnas et al found that, the common cause of moderate to 
severe thrombocytopenia in pregnancy is mainly GT, while 
ITP,   preeclampsia, and HELLP syndrome are less common.[10] 
Normal pregnancy is associated with a physiologic fall in the 
platelet count that is characterized by a leftward shift in the 
platelet count distribution.[11] The reason for this decline is 
unknown, although it has been speculated that these changes 
may reflect dilution, decreased platelet production, or 
increased platelet turnover during pregrancy.[12] Regardless, 
the fall in the platelet count during normal pregnancy results 
in some pregnant women developing platelet counts that 
falls into the thrombocytopenic range. Generally, these 
individuals have mild thrombocytopenia that first becomes 
apparent in the mid-second to third trimester of pregnancy. 
Although there is no well established minimum value for the 
platelet count in gestational thrombocytopenia, most experts 
consider this diagnosis to be less likely when the platelet 
count falls below 70,000/µl. the common cause of decreased 
platelets count result from physiological fall in platelets 
count, this change may reflect dilution, decreased or 







There are decreased  in platelets count at different stages of 
pregnancy, most low platelet  counts observed in the 
pregnant patients are due to normal physiologic changes. 
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